Oral Oncology
Volume 38, Issue 6 , Pages 584-590 , September 2002

Thymidine phosphorylase expression in oral squamous cell carcinoma

Received 12 September 2001 ,Accepted 15 October 2001.

References 

  1. Iltzsch MH, el Kouni MH, Cha S. Kinitic studies of thymidine phosphorlase from mouse liver. Biochemistry. 1985;24:6799–6807
  2. Friedkin D, Roberts D. The enzymatic synthesis of nucleosides. Journal of Biological Chemistry. 1954;207:245–256
  3. Krenisky TA, Koszalka GW, Tuttle JV. Purine nucleoside synthesis, and efficient method employing nucleoside phosphorylase. Biochemistry. 1981;20:3615–3621
  4. Weber G. Biochemical strategy of cancer cells and the design of chemotherapy (GHA Clowes Memorial Lecture). Cancer Research. 1983;43:3466–3492
  5. Furukawa T, Yoshimura A, Sumisazawa T, Haraguchi M, Akiyama S. Angiogenic factor. Nature (Lond). 1992;356:668
  6. Ueda M, Terai Y, Kumagai K, Ueki K, Okamoto Y, Ueki M. Correlation between tumor angiogenesis and expression of thymidine phosphorylase, and patient outcome in uterine cervical carcinoma. Human Pathology. 1999;30:1389–1394
  7. Takebayashi Y, Natsugoe S, Baba M, Akiba S, Fukumoto T, Miyadera K, et al.  Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer. 1999;85:282–289
  8. Maeda K, Chung YS, Ogawa S, Takatsuka S, Kang SM, Ogawa M, et al.  Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. British Journal of Cancer. 1996;73:884–888
  9. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, et al.  Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. Journal of National Cancer Institute. 1996;88:1110–1117
  10. O’Brien TS, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, et al.  Expression the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Research. 1996;56:4799–4804
  11. Fukuiwa T, Tekebayashi Y, Akiba S, Matsuzaki T, Hanamure Y, Miyadera K, et al.  Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics. Cancer. 1999;85:960–969
  12. Konno S, Takebayashi Y, Aiba M, Akiyama S, Ogawa K. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Letters. 2001;166(1):103–111
  13. Fujiwaki R, Hata K, Lida K, Maede Y, Koike M, Miyazaki K. Thymidine phosphorylase expression in progression of cervical cancer (correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis). Journal of Clinical Pathology. 1999;52(8):598–603
  14. Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, et al.  Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Research Common. 1998;30:797–803
  15. Matsuura T, Kuratate I, Teramachi K, Osaki M, Fukuda Y, Ito H. Thymidine phosphorylase (dThdPase) expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas. Cancer Research. 1999;59:5037–5040
  16. Ueda M, Terai Y, kumagai K, Ueki K, Kanemura M, Ueki M. Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. International Journal of Cancer. 2001;91(6):778–782
  17. Yamagata M, Mori M, Mimori K, Mafuni K-I, Tanaka Y, Ueo H, et al.  Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer. British Journal of Cancer. 1998;79:565–569
  18. Shimaoka S, Matsushita S, Nitanda T, Matsuda A, Nioh T, Akiba S, et al.  The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma. Cancer. 2000;88:2220–2227
  19. Hermanek P, Sobin LS. UICC TNM classification of malignant tumors. Berlin, Heidelberg, New York, London, Paris: Springer-Verlag; 1987;
  20. Pindborg JJ, Reichart PA, Smith CJ, Waal van der I. Histological typing of cancer and precancer of the oral mucosa, 2nd ed. World Health Organization: Springer-Verlag; 1997;
  21. Anneroth G, Hensen LS. Methodological study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res. 1984;92:448–468
  22. Yao L, Zhao YL, Itoh S, Wada S, Yue L, Furuta I. Thrombospondin-1 expression in oral squamous cell carcinomas (correlations with tumor vascularity, clinicopathological features and survival). Oral Oncology. 2000;36:539–544
  23. Yao L, Iwai I, Furuta I. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncology. 1999;35(1):56–62
  24. Michi Y, Morita I, Amagasa T, Murota S. Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. Oral Oncology. 2000;36(1):81–88
  25. Fox SB, Westwood M, Moghaddam A, Comely M, Turley H, Whitehouse RM, et al.  The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. British Journal of Cancer. 1996;73:275–280

PII: S1368-8375(01)00113-0

Oral Oncology
Volume 38, Issue 6 , Pages 584-590 , September 2002

Article Tools

* Image Usage & Resolution